Kyoung Woon Kim
Overview
Explore the profile of Kyoung Woon Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
283
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Min J, Kim K, Kim B, Doh K, Choi M, Choi B, et al.
PLoS One
. 2016 Sep;
11(9):e0162964.
PMID: 27631619
It is well known that pre-transplant B cell activating factor (BAFF) levels are associated with the development of de novo anti-HLA antibodies and antibody mediated rejection post-transplant. However, the clinical...
12.
Yu J, Kim K, Kim B, Chung B, Cho M, Choi B, et al.
Korean J Intern Med
. 2016 Mar;
31(3):552-9.
PMID: 26968190
Background/aims: Sirolimus (SRL) is a promising immunosuppressant replacingcalcineurin inhibitors (CNIs). This study was performed to evaluate the safetyand immunologic benefits of conversion to SRL in stable kidney transplant (KT)recipients exposed...
13.
Chung B, Kim K, Kim B, Doh K, Cho M, Yang C
PLoS One
. 2015 Dec;
10(12):e0145258.
PMID: 26717145
This study was performed to determine the association of Th17 cell phenotype with chronic allograft dysfunction in kidney transplant recipients (KTRs). We compared the expression of Th17 cell phenotype in...
14.
Jung S, Kim K, Yang C, Park S, Ju J
J Immunol Res
. 2014 Oct;
2014:263625.
PMID: 25295284
Bone homeostasis, which involves formation and resorption, is an important process for maintaining adequate bone mass in humans. Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation and bone...
15.
Kim K, Chung B, Kim B, Cho M, Yang C
Immunology
. 2014 Jul;
144(1):68-78.
PMID: 24974886
Sirolimus (SRL) is a promising alternative to calcineurin inhibitors, such as tacrolimus (TAC), in kidney transplant recipients (KTRs), but the immunological benefits of conversion from calcineurin inhibitors to SRL are...
16.
Chung B, Kim K, Yu J, Kim B, Choi B, Park C, et al.
Transpl Immunol
. 2014 Apr;
30(4):159-67.
PMID: 24709525
B lymphocytes are known to play a role in kidney transplantation (KT) outcomes. Here, we evaluated the proportion of B cell subsets before and after KT. Twenty-one patients, who showed...
17.
Chung B, Kim K, Kim B, Piao S, Lim S, Choi B, et al.
PLoS One
. 2012 Aug;
7(7):e42011.
PMID: 22848688
Accumulating evidence suggests that Th17 cells play a role in the development of chronic allograft injury in transplantation of various organs. However, the influence of current immunosuppressants on Th17-associated immune...
18.
Kim K, Chung B, Jeon E, Kim B, Choi B, Park C, et al.
Exp Mol Med
. 2012 May;
44(8):465-72.
PMID: 22617684
Most of the previous studies on immune dysregulation in end-stage renal disease (ESRD) have focused on T cell immunity. We investigated B cell subpopulations in ESRD patients and the effect...
19.
Chung B, Kim K, Sun I, Choi S, Park H, Jeon E, et al.
Immunol Lett
. 2011 Oct;
141(2):181-9.
PMID: 22004873
Patients with end-stage renal disease (ESRD) exhibit immune dysregulation, but the precise immunological profile and the effect of hemodialysis (HD) on it has not been investigated fully. Thirty-eight ESRD patients...